This week, Emulate announced new funding and research partnerships that will advance the technology, which has significant potential for cosmetic and personal care development and testing.
India is moving towards a shake up in its cosmetics regulation in order to keep up with the rapid pace of today’s innovation, with its union cabinet having just withdrawn the country’s Drugs and Cosmetics (Amendment) Bill of 2013.
A new Drugs and Cosmetics (Amendment) Bill to be introduced in the ongoing session of India’s Parliament aims to create a Central Drug Authority similar to the USA’s FDA.
Allergan has long dominated the anti-wrinkle arena with its Botox product, but it appears cosmo-pharma giant Johnson & Johnson is preparing to offer serious competition, with the development of its latest drug.
Skinvisible has signed a partnership with RHEI Pharmaceuticals of Belgium, allowing it to license its dermatology products in China, Hong Kong and Taiwan.
Eyelash enhancers have blurred the line between cosmetics and drugs
landing two companies in a regulatory snare but La Canada Ventures
has been careful to avoid trouble.
Preliminary studies find that a nanotech drug delivery system has
been developed to increase the efficacy of a prescription tanning
agent for fair-skinned people, reports Phil Taylor and Simon
Pitman.